Picard Medical (PMI) announced that a 29-year-old patient received a donor heart transplant after living for more than four years supported entirely by the SynCardia Total Artificial Heart. The patient was implanted with the SynCardia Total Artificial Heart on September 2, 2021, after developing severe biventricular heart failure. The device replaced the pumping function of both sides of the heart, maintaining circulation while the patient awaited a donor organ. After 1,636 days of continuous artificial heart support, the patient underwent a successful heart transplant on February 24, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PMI:
- Picard Medical Shareholders Approve Expanded Capital Stock Authorization
- Picard Medical Showcases SynCardia Artificial Heart on BTV
- Picard Medical Schedules Annual Business and Cardiothoracic Update
- Picard Medical Highlights Advancements in Total Artificial Heart Therapy
- Picard announces 3 presentations on STAH, next-generation Emperor system